GI
NDRM

GAMCO Investors’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

GAMCO Investors’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-38,810
Closed -$1.51M – 881
2017
Q3 		$1.51M Buy
+38,810
New +$1.43M 0.01% 525

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

GAMCO Investors's NDRM Position: Q4 2017 in Review

GAMCO Investors sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 38,810 shares — an estimated $1.51M sold.

GAMCO Investors first reported a position in NDRM in Q3 2017 and held it in 1 quarter. The position peaked at $1.51M in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • GAMCO Investors reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • GAMCO Investors sold 38,810 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $1.51M.
  • GAMCO Investors first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2017 and held it in 1 quarter.
  • GAMCO Investors's NeuroDerm Ltd. Ordinary Shares position peaked at $1.51M in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on GAMCO Investors's 13F filing for Q4 2017, filed 2 Feb 2018.